Finance

Lists
BVNRY:OTCMKTS
Bavarian Nordic A/S - ADR
$ 10.84
+0.23%
(+0.025) 1D
10-р сарын 2, 16:00:00 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BVNRY...
Open
$ 10.83
High
$ 10.85
Low
$ 10.74
Mkt. cap
2.61 тэрбум
Avg. vol.
3.68 мян
Volume
9.14 мян
P/E ratio
11.59
52-wk high
$ 13.00
52-wk low
$ 8.67
EPS
$ 0.93
Beta
1.45
Shares outstanding
237.82 сая
No. of employees
2 мян
Open
$ 10.83
High
$ 10.85
Low
$ 10.74
Mkt. cap
2.61 тэрбум
Avg. vol.
3.68 мян
Volume
9.14 мян
P/E ratio
11.59
52-wk high
$ 13.00
52-wk low
$ 8.67
EPS
$ 0.93
Beta
1.45
Shares outstanding
237.82 сая
No. of employees
2 мян
News stories
From web sources and news partners
Profile
Bavarian Nordic A/S is a Danish biotechnology company focused on the development, manufacturing and commercialization of vaccines. The company is headquartered in Hellerup, Denmark, with manufacturing facilities in Kvistgård, Denmark and Thörishaus near Bern, Switzerland. The company has research and development facilities in Martinsried, Germany, as well as offices in USA, Canada, and France. The company uses viral vectors and virus-like particles in its research and development. In July 2025, the company agreed to be acquired by private equity firms Permira and Nordic Capital for 19 billion kr. However, in November, the acquisition failed to gain sufficient support from Bavarian Nordic's shareholders, leading to its termination. In 2026, Bavarian Nordic was ranked second in Time Magazine's World Most Impactful Companies. Wikipedia
About Bavarian Nordic A/S - ADR
CEOPaul Chaplin
Employees1.91 мян
Founded1992 оны 7-р сарын 1
Headquarters-
Sector-
Previous reportsAll values in DKK
Loading Previous Earnings...
Revenue
Net income
All values in DKK
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
1.79 тэрбум
1.45 тэрбум
1.06 тэрбум
2.03 тэрбум
Cost of goods sold
901.84 сая
866.52 сая
583.64 сая
803.15 сая
Cost of revenue
901.84 сая
866.52 сая
583.64 сая
803.15 сая
Research and development expenses
133.20 сая
181.74 сая
175.14 сая
163.43 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
415.41 сая
352.14 сая
306.07 сая
319.05 сая
Operating expense
548.52 сая
533.88 сая
481.21 сая
482.48 сая
Total operating expenses
1.45 тэрбум
1.40 тэрбум
1.06 тэрбум
1.29 тэрбум
Operating income
344.56 сая
50.55 сая
-7.01 сая
748.77 сая
Other non operating income
-1.75 сая
-1.74 сая
-1.71 сая
-1.74 сая
EBT including unusual items
1.17 тэрбум
28.19 сая
23.32 сая
759.63 сая
EBT excluding unusual items
361.71 сая
62.45 сая
23.72 сая
760.01 сая
Income tax expense
77.02 сая
326.99 сая
6.36 сая
27.99 сая
Effective tax rate
6.58%
1,159.86%
27.30%
3.68%
Other operating expenses
-88.00 мян
-
-
-
Net income
1.09 тэрбум
-298.80 сая
16.95 сая
731.64 сая
Net profit margin
60.89%
-20.59%
1.60%
35.96%
Earnings per share
-
-3.30
-
8.90
Interest and investment income
12.90 сая
19.84 сая
14.86 сая
13.06 сая
Interest expense
-1.37 сая
-2.18 сая
-1.41 сая
-3.56 сая
Net interest expenses
11.53 сая
17.66 сая
13.45 сая
9.50 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
515.50 сая
166.77 сая
165.45 сая
924.55 сая
Gain or loss from assets sale
-
18.43 сая
-
-
AI content may include mistakes. Learn more
Google аппс